Polymers for controlled release: Formulation follows function

Pharmaceutical Technology

Volumn 29, Issue 6, 2005, Pages 42-50

  Rios, Maribel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLYMERS;

FORMULATION; PROCESSABILITY;

DRUG PRODUCTS;

COPOLYMER; GRANULOCYTE COLONY STIMULATING FACTOR; KOLLICOAT SR; KOLLIDON SR; MICROSPHERE; POLOXAMER; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; POLYMER; POLYVINYL ACETATE; POVIDONE; RK 0202; UNCLASSIFIED DRUG;

BIODEGRADABILITY; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG STABILITY; HUMAN; INHALATION; MOLECULAR WEIGHT; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; REVIEW; SUSTAINED RELEASE PREPARATION; TABLET;

EID: 20444424557     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. J. Yuan, N.M. Clipse, and S.H. Wu, "The Effects of Alternating Combinations of an Enteric Coating and HPMC as Inner and Outer Coatings on the Performance of Coated Aspirin Tablets," Pharm. Technol. 27 (11), 70-82 (2003).
2. A.M. Kaushal and S. Garg, "An Update on Osmotic Drug Delivery Patents," Pharm. Technol. 27 (8), 38-44, 97 (2003)
3. S. Apte and S.O. Ugwu, "A Review and Classification of Emerging Excipients in Parenteral Medications," Pharm. Technol. 27 (3), 46-60 (2003).
4. S.K. Nachaegari and A.K. Bansal, "Coprocessed Excipients for Solid Dosage Forms," Pharm. Technol. 28(1), 52-64 (2004).